
M JOSE SERRANO Lab (LB&Cancer Interception group)
@mjoseserrano19
Scientific director of Liquid Biopsy & Cancer Interception Group.HUVN-GENyO
Founder and Vicepresident of the ISLB
ID: 3337387155
http://www.genyo.es 20-06-2015 18:43:24
3,3K Tweet
1,1K Followers
682 Following

Happy to see our collaborative paper "Metatranscriptomic analysis reveals gut microbiome bacterial genes in pyruvate and amino acid metabolism associated with hyperuricemia and gout in humans" published Fundación Progreso y Salud Instituto Nacional de Rehabilitación IBiS nature.com/articles/s4159…



🧬 Brilliant take of Umberto Malapelle on biomarker detection rates, treatment impact, and adoption across Europe using CGP vs. single-gene testing in lung cancer 🔬 Precision oncology starts with diagnostic accuracy and timely testing 📊 #LCSM #ELCC25 #CGP #Biomarkers


Voci di corridoio mi suggeriscono che Umberto Malapelle e Alfonso De Stefano, prima di diventare famosi, studiassero come cambiare il mondo sulle scale del Dipartimento di Sanità Pubblica - UniNA 😜


Our Memorial Cancer Institute Memorial Healthcare System #lungcancer team just did a review of Incidental Pulmonary nodules and the important role of these programs in #lungcancer screening featuring our IPN program #lcsm @flasco OLACANCER Schmidt College of Medicine at Florida Atlantic Florida Atlantic University Lung Cancer Europe Lung Cancer Research Foundation



Take a look Lung-MAP 3.0! Better for patients, better for doctors treating them, better for clinical trial accrual and completion. Join in! Foundation for the National Institutes of Health National Cancer Institute SWOG Cancer Research Network

Navigating the future of #LiquidBiopsy with Christian at #poles25 OneCell Diagnostics Aravindan Vasudevan From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer. Tissue vs liquid? It’s not a battle—it’s a partnership. #Oncology


Headed to Austin for Texas Lung Conference 2025. Speaking on status of MRD assays in Early-Stage NSCLC. Cannot think of a more appropriate title than the famous editorial title "Can that Dog Hunt" by DH Johnson. Tina Cascone. Stephen V Liu, MD Heather Wakelee IASLC


🚨 ESMO’s New Global Guidelines for Molecular Tumor Boards (MTBs) 🧬💻 Published in Annals of Oncology, this comprehensive special article by Ben Westphalen et al. and the ESMO - Eur. Oncology Precision Oncology Working Group delivers international recommendations to standardize MTB


🚨 New Perspective on ctDNA in NSCLC: Understanding Acquired Resistance 🧬🩸 📖 NatureRevClinOncol , 2025 🔬 This expert review outlines how circulating tumor DNA (ctDNA) is reshaping the detection of acquired resistance to targeted therapies in metastatic NSCLC. 🔍 Key








🚨📣🩸participate on the first global survey on attitudes, practices & barriers to #LiquidBiopsy use among clinical oncologists! 🌍 International Society of Liquid Biopsy It takes just 10 minutes⏰ and it will help to shape the future of cancer care! 👉 docs.google.com/forms/d/e/1FAI…

